Cargando…

Associations between testosterone and metabolic syndrome in depressed and non‐depressed older men and women

OBJECTIVES: Older age and major depressive disorder (MDD) are both risk factors for the development of cardiovascular diseases. Testosterone has been associated with MDD and metabolic syndrome (MetS) in men, although associations in women are less clear. Therefore, we investigated whether testostero...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Wit, Anouk E., Giltay, Erik J., de Boer, Marrit K., Bosker, Fokko J., van der Mast, Roos C., Comijs, Hannie C., Oude Voshaar, Richard C., Schoevers, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590367/ https://www.ncbi.nlm.nih.gov/pubmed/30474223 http://dx.doi.org/10.1002/gps.5040

Ejemplares similares

Plasma androgens and the presence and course of depression in a large cohort of women
por: de Wit, Anouk E., et al.
Publicado: (2021)

The two-year course of late-life depression; results from the Netherlands study of depression in older persons
por: Comijs, Hannie C, et al.
Publicado: (2015)

Hormonal contraceptive use and depressive symptoms: systematic review and network meta-analysis of randomised trials
por: de Wit, Anouk E., et al.
Publicado: (2021)

Symptomatic and functional recovery in depression in later life
por: Collard, Rose M., et al.
Publicado: (2018)

The Netherlands study of depression in older persons (NESDO); a prospective cohort study
por: Comijs, Hannie C, et al.
Publicado: (2011)

Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study
por: Beijers, Lian, et al.
Publicado: (2019)

Lifestyle factors and the course of depression in older adults: A NESDO study
por: Bruin, Myrthe C., et al.
Publicado: (2018)

Determinants and consequences of polypharmacy in patients with a depressive disorder in later life
por: Wiersema, Carlijn, et al.
Publicado: (2022)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Huntingtin gene repeat size variations affect risk of lifetime depression
por: Gardiner, Sarah L., et al.
Publicado: (2017)

N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
por: Yang, Chenghao, et al.
Publicado: (2018)

Large normal-range TBP and ATXN7 CAG repeat lengths are associated with increased lifetime risk of depression
por: Gardiner, S L, et al.
Publicado: (2017)

Association between adolescent oral contraceptive use and future major depressive disorder: a prospective cohort study
por: Anderl, Christine, et al.
Publicado: (2021)

Metabolomics signatures of depression: the role of symptom profiles
por: de Kluiver, Hilde, et al.
Publicado: (2023)

Functional improvement by behavioural activation for depressed older adults
por: Janssen, Noortje P., et al.
Publicado: (2023)

Metabolomic profiles discriminating anxiety from depression
por: de Kluiver, Hilde, et al.
Publicado: (2021)

Mouse repeated electroconvulsive seizure (ECS) does not reverse social stress effects but does induce behavioral and hippocampal changes relevant to electroconvulsive therapy (ECT) side-effects in the treatment of depression
por: van Buel, Erin M., et al.
Publicado: (2017)

Late-life depression symptom dimensions and cognitive functioning in the Longitudinal Aging Study Amsterdam (LASA)
por: Brailean, Anamaria, et al.
Publicado: (2016)

Daily associations between affect and cognitive performance in older adults with depression and cognitive impairment: a series of seven single-subject studies in the Netherlands
por: Tieks, Alieke, et al.
Publicado: (2022)

Bioavailable testosterone is associated with symptoms of depression in adult men
por: Chen, Zhongbao, et al.
Publicado: (2020)

Depression in men with testosterone deficiency (Preliminary results of the study)
por: Osadshiy, Y., et al.
Publicado: (2022)

Subtyping late-life depression according to inflammatory and metabolic dysregulation: a prospective study
por: Kokkeler, K. J. E., et al.
Publicado: (2022)

Non-pharmacological treatment for depressed older patients in primary care: A systematic review and meta-analysis
por: Holvast, Floor, et al.
Publicado: (2017)

A prospective study into change of vitamin D levels, depression and frailty among depressed older persons
por: van den Berg, Karen S., et al.
Publicado: (2021)

Adolescent oral contraceptive use and future major depressive disorder
por: Wit, A. De, et al.
Publicado: (2021)

Effect of Testosterone Replacement Therapy on Cognitive Performance and Depression in Men with Testosterone Deficiency Syndrome
por: Jung, Hyun Jin, et al.
Publicado: (2016)

Relationship between testosterone levels and depressive symptoms in older men in Amirkola, Iran
por: Kheirkhah, Farzan, et al.
Publicado: (2014)

Stepped-care to prevent depression and anxiety in visually impaired older adults – design of a randomised controlled trial
por: van der Aa, Hilde PA, et al.
Publicado: (2013)

Can loss of agency and oppositional perturbation associated with antidepressant monotherapy and low-fidelity psychological treatment dilute the benefits of guideline-consistent depression treatment at the population level?
por: Ormel, Johan, et al.
Publicado: (2020)

The Frail Depressed Patient: A Narrative Review on Treatment Challenges
por: Aprahamian, Ivan, et al.
Publicado: (2022)

Partial Androgen Deficiency, Depression, and Testosterone Supplementation in Aging Men
por: Amore, Mario, et al.
Publicado: (2012)

Serum Testosterone Levels and Symptom-Based Depression Subtypes in Men
por: Rodgers, Stephanie, et al.
Publicado: (2015)

When a patient with depression is feeling sleepy, be aware of sleep apnoea
por: Wiersema, Carlijn, et al.
Publicado: (2018)

Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder
por: Lokkerbol, Joran, et al.
Publicado: (2020)

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2021)

Effectiveness of late‐life depression interventions on functional limitations: A systematic review
por: Wassink‐Vossen, Sanne, et al.
Publicado: (2022)

Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial
por: van der Aa, Hilde P. A., et al.
Publicado: (2017)

The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case–control association study
por: Yang, Chenghao, et al.
Publicado: (2021)

Blood Brain-Derived Neurotrophic Factor (BDNF) and Major Depression: Do We Have a Translational Perspective?
por: Arosio, Beatrice, et al.
Publicado: (2021)

Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial
por: van der Aa, Hilde P A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9pc8l2rom85geg04705r7hlgnp